Multiple sclerosis and Deep venous thrombosis

Summary:

Deep venous thrombosis is found among people with Multiple sclerosis, especially for people who are female, 40-49 old.

The study analyzes which people have Deep venous thrombosis with Multiple sclerosis. It is created by eHealthMe based on reports of 1,698 people who have Multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Multiple sclerosis?

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,087 drugs and 1,361 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.

What is Deep venous thrombosis?

Deep venous thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis) is found to be associated with 2,068 drugs and 2,966 conditions by eHealthMe. Check the latest studies of Deep venous thrombosis.

On Jul, 13, 2026

1,698 people who have Multiple Sclerosis and Deep Venous Thrombosis are studied.

Would you have Deep venous thrombosis when you have Multiple sclerosis?

Gender of people who have Multiple sclerosis and experienced Deep venous thrombosis *:

Click here to view

Age of people who have Multiple sclerosis and experienced Deep venous thrombosis *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Deep venous thrombosis?

- Check whether Deep venous thrombosis is associated with a drug or a condition

Related publications that referenced our studies

Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .

Related studies:

Treatments, associated drugs and conditions:

Multiple sclerosis (799,636 reports)
Deep venous thrombosis (130,305 reports)

All the drugs that are associated with Deep venous thrombosis:

Deep venous thrombosis (2,068 drugs)

All the conditions that are associated with Deep venous thrombosis:

Deep venous thrombosis (2,966 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Deep venous thrombosis and Multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.